COVID-19 Vaccination Might Induce Reversible Cerebral Vasoconstriction Syndrome Attacks: A Case Report
Open Access
Abstract
A 30-year-old male diagnosed three years previously with reversible cerebral vasoconstriction syndrome (RCVS) presented to the department of neurology with an accumulation of attacks mimicking previous RCVS attacks and fulfilling the diagnostic criteria for RCVS after receiving the first Pfizer COVID-19 vaccine. The neurologic exam, blood samples, electrocardiogram (ECG), and computer tomography of the head (CTC) were normal. The patient was treated with the angiotensin 2 receptor antagonist, losartan, with a good response and was discharged with a prescription for losartan lasting until three days after the second Pfizer COVID-19 vaccine. No further RCVS attacks were reported. These findings indicate that the COVID-19 vaccine might induce RCVS attacks in susceptible individuals, and targeting the angiotensin 2 receptor could be a preventive option.Keywords
This publication has 13 references indexed in Scilit:
- Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine DesignViruses, 2021
- SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 VaccinesVaccines, 2021
- Candesartan in migraine prevention: results from a retrospective real-world studyJournal of Neurology, 2020
- Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infectionJournal of Stroke and Cerebrovascular Diseases, 2020
- SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapyTheranostics, 2020
- Nimodipine Reappraised: An Old Drug With a FutureCurrent Neuropharmacology, 2019
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd editionCephalalgia, 2018
- Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical CourseAmerican Journal of Neuroradiology, 2015
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- Narrative Review: Reversible Cerebral Vasoconstriction SyndromesAnnals of Internal Medicine, 2007